Literature DB >> 22126560

Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider.

Juhi Upadhyay1, Nirmala N Rao, Ram B Upadhyay, Pankaj Agarwal.   

Abstract

Being simple and inexpensive toluidine blue has been in use for more than two decades for the detection of potentially malignant oral lesions (PMOL's) and malignant lesions. Although there has been concensus that staining often assists in the identification of these lesions, results have been diverse. In most studies false negative were not recorded as biopsies of lesions that did not retain toluidine blue were not performed. Thus the present study attempted to evaluate the efficacy of toluidine blue vital dye for detection of PMOL's. The study included 47 biopsies (TBP:35 and TBN:12), of which 23 cases were confirmed as dysplastic (TBP=17 and TBN=6), 7 as hyperkeratosis (TBP=4 and TBN=3), 8 as epithelial hyperplasia (TBP=6 and TBN=3) and 5 as other benign lesions (TBP=4 and TBN=1). The validity test revealed a senstivity of 73.9% and specificity of 30%. The positive predictive value was 54.8% and negative predictive value of 50%. The study intends to highlight the false negative result (26.1%) which was mainly attributed to mild dysplasia and the false positive (32.6%) which included hyperkeratosis, hyperplasia, lichen planus and traumatic ulcer. The study concludes that toluidine blue staining should not blindly direct the clinician's opinion, and strongly discourages the use of toludine blue as a screening test and the results should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126560

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

Review 1.  Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct.

Authors:  Naveen Chhabra; Shruti Chhabra; Nitin Sapra
Journal:  J Maxillofac Oral Surg       Date:  2014-07-29

Review 2.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Richard Macey; Tanya Walsh; Paul Brocklehurst; Alexander R Kerr; Joseph L Y Liu; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

3.  Validity of Toluidine Blue test as a diagnostic tool for high risk oral potentially malignant disorders- a multicentre study in Sri Lanka.

Authors:  R D Jayasinghe; P V K S Hettiarachchi; Dilrukshi Amugoda; Menaka Kumaraarachchi; R L P R Liyanage; B S M S Siriwardena; Ranjith Gunasena; A H T S Karunatilake; H K Amarasinghe
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-19

4.  Comparative efficacy of chemiluminescence and toluidine blue in the detection of potentially malignant and malignant disorders of the oral cavity.

Authors:  Abhilasha Shukla; Narendra Nath Singh; Sangeeta Adsul; Sulabh Kumar; Deepika Shukla; Anubhuti Sood
Journal:  J Oral Maxillofac Pathol       Date:  2018 Sep-Dec

5.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20

6.  Acetic acid as an adjunct vital stain in diagnosis of tobacco-associated oral lesions: A pilot study.

Authors:  D P Vinuth; Poonam Agarwal; Alka D Kale; Seema Hallikeramath; Deepika Shukla
Journal:  J Oral Maxillofac Pathol       Date:  2015 May-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.